In an up-to-date review of most of the common neurological disorders in the United States published in the January 30, 2007, issue of Neurology, the scientific journal of the American Academy of Neurology, researchers reviewed studies from nearly 500 articles published between 1990 and 2005 to determine the best available data.
Children with sickle cell disease who experienced major complications such as pain and lung disease early in life are at no greater risk for stroke or death during later childhood, new research from UT Southwestern Medical Center shows.
Joslin researchers discover protein that causes blood vessel leakage and swelling in eyes with diabetic retinopathy. Discovery one day could lead to new treatments for eye diseases and brain swelling caused by head injury, stroke and other conditions.
Every twenty-eight seconds, someone in America suffers a stroke, a massive seizure, a brain or spinal cord injury, or another major emergency affecting the brain, spine or nerves. Every two minutes, someone dies from one of these conditions. Many others are left permanently disabled.
Patients treated at top-rated hospitals nationwide have nearly a one-third better chance of surviving, on average, than those admitted to all other hospitals, according to a study released today by HealthGrades, the leading independent healthcare ratings company.
Genentech’s Lucentis, a recently approved drug to treat macular degeneration (AMD) in the elderly may increase a person’s risk of getting a stroke.
Brain damage to insula may halt urge to smoking, findings appeared in the journal Science, published by AAAS.
Results from the most comprehensive study to compare two imaging techniques for the emergency diagnosis of suspected acute stroke show that magnetic resonance imaging (MRI) can provide a more sensitive diagnosis than computed tomography (CT) for acute ischemic stroke.
Stem cells taken from adult human bone marrow have been manipulated by scientists at the Maxine Dunitz Neurosurgical Institute at Cedars-Sinai Medical Center to generate aggregates of cells called spheres that are similar to those derived from neural stem cells of the brain.
Engineering Conferences International is sponsoring a second conference on Light-Activated Tissue Regeneration and Therapy to be held in Portugal this coming June.